Page last updated: 2024-11-10

isoretronecanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

isoretronecanol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080563
SCHEMBL ID19317460
MeSH IDM0147117

Synonyms (20)

Synonym
isoretronecanol
[(1s,8s)-2,3,5,6,7,8-hexahydro-1h-pyrrolizin-1-yl]methanol
unii-661h3381js
1h-pyrrolizine-1-methanol, hexahydro-, (1s-trans)-
661h3381js ,
526-63-6
SCHEMBL19317460
1h-pyrrolizine-1-methanol, hexahydro-, (1s,7as)-
(-)-isoretronecanol
heliotridane, 9-hydroxy-
isoretronecanol, (-)-
2,3,5,6,7,7a.alpha.-hexahydro-1h-pyrrolizine-1.beta.-methanol
9-hydroxyheliotridane
DTXSID50200578
D74235
Q27263929
CS-0080635
((1s,7as)-hexahydro-1h-pyrrolizin-1-yl)methanol
[(1s,7as)-hexahydro-1h-pyrrolizin-1-yl]methanol
AKOS040734790
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]